The Hospital Clínico San Carlos is a hospital located at the Ciudad Universitaria neighborhood in Madrid, Spain, part of hospital network of the Servicio Madrileño de Salud. It is one of the healthcare institutions associated to the Complutense University of Madrid for the purpose of clinical internship.

There are 861 beds in Hospital Universitario Clínico San Carlos; Servicio de Oncologia.

During the past decade, Hospital Universitario Clínico San Carlos; Servicio de Oncologia conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 22 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" are "Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Carcinoma, Hepatocellular" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" are "Drug" (45 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (18 trials), "Carboplatin" (11 trials), "Paclitaxel" (10 trials), "Placebo" (10 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" are 40 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia". undefined are not yet recruiting, 4 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hospital Universitario Clínico San Carlos; Servicio de Oncologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Clínico San Carlos; Servicio de Oncologia, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".